Combination of BRAF Inhibitors and Brain Radiotherapy in Patients With Metastatic Melanoma Shows Minimal Acute Toxicity

Serious Skin Toxicity With the Combination of BRAF Inhibitors and Radiotherapy

(2013) Imke Satzger et al.   JOURNAL OF CLINICAL ONCOLOGY

Vemurafenib and radiation therapy in melanoma brain metastases

(2013) Ashwatha Narayana et al.   JOURNAL OF NEURO-ONCOLOGY

Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial

(2012) Kim Margolin et al.   LANCET ONCOLOGY

Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial

(2012) Georgina V Long et al.   LANCET ONCOLOGY

Melanoma cells show a heterogeneous range of sensitivity to ionizing radiation and are radiosensitized by inhibition of B-RAF with PLX-4032

(2011) Maria J. Sambade et al.   RADIOTHERAPY AND ONCOLOGY

Use of γH2AX and Other Biomarkers of Double-Strand Breaks During Radiotherapy

(2010) Ali Sak et al.   SEMINARS IN RADIATION ONCOLOGY